Please note: Dr. Verma will not take students in summer.
Dr Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the
University of Toronto. He is the Canada Research Chair in Cardiovascular Surgery and a past
recipient of the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research
and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He previously
served as the Canada Research Chair in Atherosclerosis (2007-2017). He is an appointee of the
American Association of Thoracic Surgeons (AATS) and a member of the College of New Scholars,
Artists and Scientists, Royal Society of Canada. According to Google Scholar in December 2020, Dr
Verma has an h-index of 107 and his work has been cited over 58,000 times.
Dr Verma has published extensively in prestigious journals like the NEJM, Lancet, Circulation, JACC,
Nature, and JCI and he is currently an Associate Editor of the European Heart Journal. Dr Verma is
an active contributor to Canadian clinical practice guidelines and recently co-authored the
recommendations for atrial fibrillation, antiplatelet therapy, heart failure and diabetes; he was a
member of the 2018 AATS consensus guidelines committee on bicuspid aortic valve-related
aortopathy. Dr Verma has served in various capacities on the American Heart Association Council
on Cardiovascular Surgery and Anesthesia since 2008.
Dr Verma has leadership roles on 7 global heart failure trials in diabetes – DAPA-HF, DELIVER,
DETERMINE-A, DETERMINE-B, EMPEROR-Preserved, EMPEROR-Reduced and SOLOIST-WHF.
He is also involved in the DAPA ACT HF-TIMI 68, FINEARTS-HF, STEP HFpEF, VESALIUS-CV,
DARE-19, SELECT and CLEAR SYNERGY trials. He founded and oversees the CardioLink platform
at St Michael’s Hospital that is conducting cardiometabolic and surgically oriented RCTs and
Dr Verma leads a dynamic pre-clinical and translational research team that leverages pre-clinical
disease models and clinical trial-derived data to identify novel mediators of cardiovascular and
cardiometabolic disease as well as answer timely and relevant healthcare questions. His research
has yielded 2 United States patents and is supported by several national peer-reviewed grants.